Schneeberger
Facing ongoing competitive pressures and market growth demands, life science and biomedical original equipment manufacturers (OEMs) must constantly deliver new advancements in technology, processes, workflows, and production. But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.
In the case of advanced instruments used in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component – in-process linear motion systems – can generate consequences ranging from inconvenient to catastrophic.
This white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing – and ensure against failures of any consequence.
Latest from Today's Medical Developments
- Arcline to sell Medical Manufacturing Technologies to Perimeter Solutions
- Decline in German machine tool orders bottoming out
- Analysis, trends, and forecasts for the future of additive manufacturing
- BlueForge Alliance Webinar Series Part III: Integrate Nationally, Catalyze Locally
- Robot orders accelerate in Q3
- Pro Shrink TubeChiller makes shrink-fit tool holding safer, easier
- Revolutionizing biocompatibility: The role of amnion in next-generation medical devices
- #56 Lunch + Learn Podcast with Techman Robot + AMET Inc.